LONDON, March 30, 2015 /PRNewswire/ -- REPORT
HIGHLIGHTS
The global market for breast cancer diagnostic and drug
technologies was about $20.8 billion
in 2012. This market reached about $22.3
billion in 2014 and is expected to reach $27 billion in 2019, registering a compound
annual growth rate (CAGR) of 4% through 2014-2019.
This report provides:
An overview of the global market for breast cancer diagnostics and
drug technologies.
Analyses of market trends, with data from 2012, estimates for 2014,
and projections of CAGRs through 2019.
A comprehensive review of emerging breast cancer personalized and
predictive diagnostic tests, particularly with regard to companion
tests, tumor markers, and gene profiling assays relevant for breast
cancer prognosis and diagnosis.
Information on products in the market and detailed analyses of the
market's segments and competitive environments.
Assessments of technological developments, product innovations, and
recent strategic industry activity of across different product
categories.
Comprehensive company profiles of major players in the
industry.
SCOPE AND FORMAT
This report provides an update and overview on predictive testing
in breast cancer diagnostics and drug technologies and global
markets as well as global incidence rates for breast cancer. The
study's objective is to review tumor marker-based predictive
companion tests and drugs for breast cancer, and then assess their
global growth potential over a five-year period from 2014 to 2019.
The comprehensive review includes global markets for current drugs,
new developments, predictive diagnostic tests and new technologies,
drugs and developments. The report forecasts market trends forecast
trends for the use of current tests for better diagnosis and
prognosis of breast cancer through 2019.
Important current diagnostic tests, technologies and developments;
market share by drug, test and current products on the market;
market share by company or product; and statistical information for
types of breast cancer incidence and prevalence globally, with
special emphasis on the U.S. market, are discussed. The report
focuses on tumor marker-based testing, which provides vital
information about the cancer.These tests can help determine the
appropriate medicine and timing of treatment to address the disease
most effectively. The report also includes information on current
issues and trends affecting the industry. The report covers
products in development, new technologies, trends, alliances, new
developments and patents and mergers. It offers market data with
respect to segments and geography. Other breast cancer detection
and screening technologies and markets (e.g., mammography,
ultrasound, biopsy) are not included in this report
Download the full report:
https://www.reportbuyer.com/product/919332/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that
provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/breast-cancer-diagnostic-and-drug-technologies-global-markets-300057906.html
SOURCE ReportBuyer